Effects of Balance Training in Individuals With Glaucoma

Browse trials for

• Glaucoma 1,846

Keywords

• Glaucoma
• Balance Training
• Postural Balance
• Fall Risk
• Fear of Falling
• Functional Mobility

Glaucoma

1,846 studies on the registry are indexed under Glaucoma; 236 are open to participants now.

This study's planned enrollment of 50 is below the median of 65 across 1,298 interventional studies indexed under Glaucoma.

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 224 studies on the registry; 34 are open to participants now.

Study arms

• Experimental
  Balance Training Group

  Participants in this group will receive a structured balance training program for 8 weeks in addition to their routine glaucoma care. The balance training program will include static and dynamic balance exercises, gait-related balance activities, and progressive postural control exercises.

  Behavioral: Balance Training Program

• No intervention
  Control Group

  Participants in this group will continue their routine glaucoma care and will not receive the balance training program during the 8-week study period. Outcome assessments will be performed at baseline and at the end of 8 weeks using the same assessment procedures as the balance training group.

Interventions

• BehavioralBalance Training Program

  Participants allocated to the intervention group will participate in a structured balance training program for 8 weeks, three days per week, with each session lasting approximately 45 minutes. The program will include static and dynamic balance exercises, such as tandem stance, single-leg stance, tandem walking, heel-to-toe walking, directional changes, sit-to-stand exercises, and progressive postural control activities. Exercise difficulty will be progressively increased according to each participant's functional capacity and tolerance. All exercise sessions will be performed under supervision, with appropriate safety precautions to minimize the risk of falls. Participants will continue their routine glaucoma treatment throughout the study.

Primary outcomes

1. Change in Balance Performance Assessed by the Berg Balance Scale

   Balance performance will be assessed using the Berg Balance Scale (BBS), a 14-item performance-based measure of static and dynamic balance. Each item is scored from 0 to 4, resulting in a total score ranging from 0 to 56. Higher scores indicate better balance performance. The change in BBS score from baseline to the end of the 8-week intervention will be evaluated.

   Time frame: Baseline and 8 weeks

Secondary outcomes

1. Change in Functional Mobility and Fall Risk Assessed by the Timed Up and Go Test (TUG)

   Functional mobility and fall risk will be assessed using the Timed Up and Go Test (TUG). Participants will be instructed to stand up from a standard chair, walk a distance of 3 meters, turn around, walk back to the chair, and sit down. The time required to complete the test will be recorded in seconds. A longer completion time indicates poorer functional mobility and a higher fall risk. The change in TUG time from baseline to the end of the 8-week intervention will be evaluated.

   Time frame: Baseline and 8 weeks

Other outcomes

1. Change in Fear of Falling Assessed by the Falls Efficacy Scale-International (FES-I)

   Fear of falling will be assessed using the Falls Efficacy Scale-International (FES-I), a 16-item questionnaire evaluating concern about falling during various daily activities. Each item is scored from 1 to 4, resulting in a total score ranging from 16 to 64. Higher scores indicate greater concern about falling. The change in FES-I score from baseline to the end of the 8-week intervention will be evaluated.

   Time frame: Baseline and 8 weeks